| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |